NOVAVAX INC - Common Stock, Par Value $0.01 per share (NVAX)

Q3 2021 13F Holders as of 30 Sep 2021

Type / Class
Equity / Common Stock, Par Value $0.01 per share
Shares outstanding
162,190,120
Number of holders
412
Total 13F shares, excl. options
37,367,414
Shares change
-2,500,447
Total reported value, excl. options
$7,745,430,573
Value change
-$523,926,966
Put/Call ratio
127%
Number of buys
237
Number of sells
-150
Price
$207.31

Significant Holders of NOVAVAX INC - Common Stock, Par Value $0.01 per share (NVAX) as of Q3 2021

514 filings reported holding NVAX - NOVAVAX INC - Common Stock, Par Value $0.01 per share as of Q3 2021.
NOVAVAX INC - Common Stock, Par Value $0.01 per share (NVAX) has 412 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 37,367,414 shares of 162,190,120 outstanding shares and own 23.04% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (6,796,998 shares), BlackRock Inc. (4,926,789 shares), RA CAPITAL MANAGEMENT, L.P. (2,097,794 shares), STATE STREET CORP (1,746,627 shares), Capital World Investors (1,478,701 shares), FMR LLC (1,461,908 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (1,371,154 shares), FRANKLIN RESOURCES INC (1,072,548 shares), GEODE CAPITAL MANAGEMENT, LLC (956,915 shares), and MORGAN STANLEY (685,624 shares).
This table shows the top 412 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.